One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Charlson Comorbidity Index: A Critical Review of Clinimetric Properties
Charlson M.E.a · Carrozzino D.b · Guidi J.b · Patierno C.b
doi : 10.1159/000521288
Psychother Psychosom 2022;91:8–35
The present critical review was conducted to evaluate the clinimetric properties of the Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long-term mortality, with regard to its reliability, concurrent validity, sensitivity, incremental and predictive validity. The original version of the CCI has been adapted for use with different sources of data, ICD-9 and ICD-10 codes. The inter-rater reliability of the CCI was found to be excellent, with extremely high agreement between self-report and medical charts. The CCI has also been shown either to have concurrent validity with a number of other prognostic scales or to result in concordant predictions. Importantly, the clinimetric sensitivity of the CCI has been demonstrated in a variety of medical conditions, with stepwise increases in the CCI associated with stepwise increases in mortality. The CCI is also characterized by the clinimetric property of incremental validity, whereby adding the CCI to other measures increases the overall predictive accuracy. It has been shown to predict long-term mortality in different clinical populations, including medical, surgical, intensive care unit (ICU), trauma, and cancer patients. It may also predict in-hospital mortality, although in some instances, such as ICU or trauma patients, the CCI did not perform as well as other instruments designed specifically for that purpose. The CCI thus appears to be clinically useful not only to provide a valid assessment of the patient’s unique clinical situation, but also to demarcate major diagnostic and prognostic differences among subgroups of patients sharing the same medical diagnosis.
Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial
Reinholt N.a,b · Hvenegaard M.c · Christensen A.B.a · Eskildsen A.d · Hjorthøj C.e,f · Poulsen S.g · Arendt M.B.d · Rosenberg N.K.b · Gryesten J.R.a · Aharoni R.N.b · Alrø A.J.d · Christensen C.W.b · Arnfred S.M.a,b,h
doi : 10.1159/000516380
Psychother Psychosom 2022;91:36–49
The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) delivered in a group format could facilitate the implementation of evidence-based psychological treatments.
A Randomized Clinical Trial of Cognitive-Behavioral Therapy for Insomnia to Augment Posttraumatic Stress Disorder Treatment in Survivors of Interpersonal Violence
Pigeon W.R.a,b · Crean H.F.b,c · Cerulli C.d · Gallegos A.M.a · Bishop T.M.a,b · Heffner K.L.a,c
doi : 10.1159/000517862
Psychother Psychosom 2022;91:50–62
Individuals exposed to interpersonal violence (IPV) commonly develop posttraumatic stress disorder (PTSD) with co-occurring depression and insomnia. Standard PTSD interventions such as cognitive processing therapy (CPT) do not typically lead to remission or improved insomnia. Cognitive behavioral therapy for insomnia (CBTi) improves insomnia in individuals with PTSD, but PTSD severity remains elevated.
Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial
Bryant R.A.a,b,c · Dawson K.S.a · Keyan D.a · Azevedo S.a · Yadav S.a · Tran J.a · Rawson N.a · Harvey S.a,c
doi : 10.1159/000520283
Psychother Psychosom 2022;91:63–72
Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic.
